Treatment for Optic Neuritis

Phase-Based Progress Estimates
Devers Eye Institute, Portland, OR
Optic Neuritis+2 More
18 - 65
All Sexes
Eligible conditions

Study Summary

This study is evaluating whether corticosteroid treatment for optic neuritis is beneficial or harmful.

See full description

Eligible Conditions

  • Optic Neuritis
  • Multiple Sclerosis

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Other trials for Optic Neuritis

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Other trials for Optic Neuritis

Trial Design

0 Treatment Group

This trial involves 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 years
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly up to 5 years for reporting.

Closest Location

Devers Eye Institute - Portland, OR

Eligibility Criteria

This trial is for patients born any sex between 18 and 65 years old. There are 6 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
A person experiences a sudden loss of vision in one eye that lasts for eight days or less. show original
A relative afferent pupillary defect and a visual field defect in the affected eye
There have been no previous episodes of optic neuritis in the affected eye. show original
No systemic disease, such as multiple sclerosis, can be the cause of the optic neuritis. show original
old People aged 18 to 46 years old are the primary target audience for the marketing campaign. show original
No previous corticosteroid treatment for optic neuritis or multiple sclerosis

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Optic Neuritis by sharing your contact details with the study coordinator.